台股 » 個股 » 旭富 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

旭富

(4119)
可現股當沖
  • 股價
    89.8
  • 漲跌
    ▲0.3
  • 漲幅
    +0.34%
  • 成交量
    52
  • 產業
    上市 生技醫療類股▲0.86%
  • 354人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
旭富 (4119)籌碼相關-福邦-新竹 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

福邦-新竹 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/03/051091.0500.0090.90102743.64%
2024/01/2600.003794.3694.60-37298-12.42%
2024/01/05399.7000.00100.0033170.95%
2024/01/04498.4300.0098.5043091.29%
2023/12/22196.3000.0096.4013100.32%
2023/12/20497.7000.0097.7043071.30%
2023/12/18597.7000.0097.5053021.66%
2023/12/142095.2300.0094.60202896.91%
2023/11/0900.00188.5089.00-1223-0.45%
2023/07/1000.001108.00108.50-1470-0.21%
2023/06/0500.001117.00117.00-1745-0.13%
2023/06/0200.004116.50116.00-4753-0.53%
2023/06/0100.006117.00116.50-6759-0.79%
2023/05/3100.0020117.75118.00-20782-2.56%
2023/05/2930115.0000.00115.00307923.79%
2023/04/192132.0000.00132.5027960.25%
2023/03/035115.005115.50114.5006220.00%
2023/02/228111.508112.13111.5007350.00%
2022/10/3100.00586.8086.40-5367-1.36%
2022/10/20186.4000.0086.9013590.28%
2022/10/1900.00188.3087.80-1357-0.28%
2022/10/1300.00387.2385.50-3348-0.86%
2022/10/1200.00190.0089.70-1338-0.30%
2022/10/11589.9000.0089.5053361.48%
2022/10/07390.1000.0091.3033350.89%
2022/09/15198.1000.0093.9012830.35%
2022/02/0800.00186.1085.80-1221-0.45%
2022/01/11183.0000.0083.1012150.46%
2020/12/3100.00183.8084.00-11,775-0.06%
2020/12/25179.8000.0084.2011,4570.07%
2020/09/2300.002121.00121.00-21,473-0.14%
2020/09/1700.001123.00123.00-11,543-0.06%
2020/09/101127.0000.00125.5011,7990.06%
2020/09/072133.2500.00132.5021,8730.11%
2020/06/2200.005144.50143.00-54,576-0.11%
2020/06/1900.005144.00143.50-54,616-0.11%
2020/06/1710148.5000.00148.00104,6570.21%
2020/06/1600.004142.00143.00-44,585-0.09%
2020/06/154144.0000.00141.5044,6010.09%
2020/06/1100.005138.50136.50-54,604-0.11%
2020/06/095143.0000.00144.0054,6530.11%
2020/06/0800.004142.50139.50-44,697-0.09%
2020/06/054141.5000.00142.0044,7510.08%
2020/05/2700.002138.50136.50-25,202-0.04%
2020/05/2600.002139.50139.50-25,224-0.04%
2020/05/2200.008152.44144.50-85,139-0.16%
2020/05/2000.004138.50139.00-44,901-0.08%
2020/05/188141.0000.00141.0084,9800.16%
2020/05/083145.0010142.00140.00-74,961-0.14%
2020/05/0710145.0000.00145.00105,0010.20%
2020/04/132141.502142.25139.5004,0480.00%
2020/04/105150.0000.00141.0053,9110.13%
2020/03/094137.884139.13138.5001,7660.00%
2020/02/191119.001121.00116.5001,1730.00%
2020/02/141116.002117.75117.50-11,006-0.10%
2020/02/131117.5000.00118.0019710.10%
2019/11/2500.001113.00112.50-11,510-0.07%
2019/11/221113.001112.00113.0001,5110.00%
2019/09/17197.6000.0098.4011,4950.07%
水星生醫*攜手旭富製藥 簽訂MTA開發抗癲癇藥物Anue鉅亨-2024/04/15
旭富新產能到位本季營運看增 觀音新廠產能再增5成Anue鉅亨-2023/10/03
星國阿茲海默三期順利解盲 旭富獨供原料藥營運吞補丸Anue鉅亨-2022/11/23
旭富 相關文章